Physician profile
Roy C Broady
NPI 1033130018
$2,487.82
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $82.70 · 2021: $905 · 2022: $689 · 2023: $439 · 2024: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $579.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $895.90 | 2019-2024 | Qulipta, Lo Loestrin Fe |
| Aspira Women'S Health INC | $502.66 | 2021-2024 | Ova1 |
| Astellas Pharma US INC | $133.09 | 2021-2023 | Veozah |
| Exeltis, USA INC. | $125.60 | 2019-2024 | Slynd |
| Ethicon US, LLC | $102.14 | 2021 | |
| Daiichi Sankyo INC. | $89.67 | 2019-2023 | Injectafer |
| Myovant Sciences INC. | $70.68 | 2022 | |
| Amgen INC. | $68.97 | 2019-2022 | |
| Avion Pharmaceuticals | $57.42 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $45.52 | 2023 | Myfembree |
| Shield Therapeutics INC | $44.01 | 2024 | |
| Evofem Biosciences, INC. | $43.95 | 2021 | |
| Mayne Pharma Commercial LLC | $43.79 | 2022-2023 | |
| Agile Therapeutics, INC. | $38.80 | 2021 | |
| Hologic Sales and Service, LLC | $29.23 | 2020-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $28.55 | 2019 | |
| Therapeuticsmd, INC. | $23.46 | 2019-2022 | |
| Lupin INC. | $22.62 | 2021 | |
| Pfizer INC. | $18.96 | 2023 | |
| Coopersurgical, INC. | $18.56 | 2024 | Summit Doppler |
| Medtronic, INC. | $16.97 | 2022 | |
| Sage Therapeutics, LLC | $16.46 | 2024 | |
| Becton, Dickinson and Company | $14.84 | 2022 | |
| Duchesnay USA Incorporated | $13.26 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.45 | 2019 | |
| Roche Diagnostics Corporation | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Broady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.